Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific...
Reexamination Certificate
2008-09-09
2008-09-09
Zeman, Robert A (Department: 1645)
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
C435S072000, C424S184100, C530S350000, C530S388100
Reexamination Certificate
active
11035884
ABSTRACT:
The present invention relates, e.g., to a glycoconjugate composition comprising one or more polysaccharide types from a cell wall polysaccharide preparation fromB. pumilusSh 18, or variants thereof. Also disclosed are antibodies generated against the glycoconjugates, and methods of using the glycoconjugates and antibodies. An antimultiorganism vaccine which reacts against at leastHaemophilus influenzaetype a,Haemophilus influenzaetype b,Staphylococcus aureus, andStaphylococcus epidermidis, is disclosed.
REFERENCES:
patent: 4356170 (1982-10-01), Jennings et al.
patent: 4644059 (1987-02-01), Gordon
patent: 5306492 (1994-04-01), Porro
patent: 2002/0119166 (2002-08-01), Pier et al.
patent: 2004/0213804 (2004-10-01), Michon et al.
Archibald et al (The glycerol teichoic acid from walls ofStaphylococcus epidermidis12, Biochem. J., 1968; 110: 583-588).
Pozsgay et al (Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of O-specific polysaccharide fromShigella dysenteriaetype 1, Proc. Natl. Acad. Sci. USA, 1999; 96: 5194-97).
Myerowitz et al (Polysaccharides of the genusBacilluscross-reactive with the capsular polysaccharides ofDiplococcus pneumoniaeType III,Haemophilus influenzaeType b andNeisseria meningitidisGroup A, Infection and Immunity, 1973; 8(6): 896-900).
Greenspan et al. (Nature Biotechnology 17: 936-937, 1999).
Myerowitz et al. (1973), Polysaccharides of the GenusBacillusCross-Reactive with the Capsular Polysaccharides ofDiplococcus pneumoniaeType III,Haemophilus influenzaeType b, andNeisseria meningitidesGroup A,Infection and Immunity8, 896-900.
Argaman et al. (1974), Polyribitol-Phosphate: An Antigen for Four Gram-Positive Bacteria Cross-Reactive with the Capsular Polysaccharide ofHaemophilus influenzaeType B,J. Immunol.112, 649-655.
Bradshaw et al. (1971), Bacterial Antigens Cross-Reactive with the Capsular Polysaccharide ofHaemophilus influenzaeType b,The Lancet1(7709), 1095-1096.
Pozsgay et al. (1999) Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide fromShigella dysenteriatetype 1,Proc Natl Acad SciUSA 96, 5194-5197.
Schneerson et al. (2003) Poly (v-D-glutamic acid) protein conjugates induce IgG antibodies in mice to the capsule ofBacillus anthracis: A potential addition to the anthrax vaccine,Proc Natl Acad SciUSA 100, 8945-8950.
Kubler-Kielb et al. (2004) Chemical Structure, Conjugation, and Cross-Reactivity ofBacillus pumilusSh18 Cell Wall Polysaccharide,J Bacteriol, 186, 6891-6901).
Zielen et al. (1996), Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates,J. Immunol Methods, 193, 1-7.
Archibald et al. (1966), The Teichoic Acids,Adv Carbohydr Chem Biochem. 21, 323-75.
Naumova et al. (1997), Anionic Polymers in Cell Walls of Gram-Positive Bacteria,Biochemistry(Mosc). 62, 809-40.
Sutton et al. (1985), An Avidin-Biotin Based ELISA for Quantitation of Antibody to Bacterial Polysaccharides,J Immunol Methods82, 215-24.
Myerowitz et al. (1973), Induction ofHaemophilius influenzaeType b Capsular Antibody in Neonatal Rabbits by Gastrointestinal Colonization with Cross-ReactingEscherichia coli, Infection and Immunity7, 137-140.
Kojima et al.(1985), Structure of the Linkage Unites Between Ribitol Teichoic Acids and Peptidoglycan,J Bacteriol, 161, 299-306).
Kojima et al.(1985), Structural studies on the linkage unit between (N-acetylglucosamine 1-phosphate) and peptidoglycan in cell walls ofBacillus pumilusAHU 1650,Eur J Bacteriol.149, 331-336.
Kubler-Kielb Joanna
Robbins John B.
Schneerson Rachel
Axelrod Nancy J.
The United States of America as represented by the Department of
Tongue Lakia J
Venable LLP
Wiseman Thomas G.
LandOfFree
Antimultiorganism glycoconjugate vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimultiorganism glycoconjugate vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimultiorganism glycoconjugate vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3909545